Work

[Expression of YARS1 in hepatocellular carcinoma and its prognostic effect].

Year: 2025

Type: other

Abstract: is associated with the progression and prognosis of hepatocellular carcinoma. Therefore, this gene is expected to become a novel biomarker and a sort of target for biological therapy in hepatocellular carcinoma.

Source: PubMed

DOI: 10.3760/cma.j.cn501113-20231203-00259

Authors: L H Hu, J Pan, H Cheng, T T Yao, J D Qian, L J Cao, M Chai, J Y Chai, G Q Wang, Y Wang

Institutions: Peking University First Hospital, Peking University People's Hospital, First Hospital of Jilin University, Anhui Medical University, Second Affiliated Hospital of Anhui Medical University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Natural Science Foundation of China

Awards: G1517486309, G4994829966

OpenAlex ID: W4408245675

Cites:

Cited by:

Related to: 10